Sponsor: Grayken Center for Addiction TTA, a program of Boston Medical Center Description: This training provides an overview of the 3 FDA-approved medications for the treatment of opioid use disorder (OUD): buprenorphine, methadone, and naltrexone. This training satisfies 1.00 hours of the required 8 hours of training for DEA-registered practitioners. Intended audience: Medical professionals with prescriptive authority, nurses and support staff who support them looking to increase provision of care for patients with substance use disorder. Objectives… Read more »
Co-Occurring Psychiatric Illness and Substance Use Disorder
Sponsor: Grayken Center for Addiction TTA, a program of Boston Medical Center Description: This training will identify common co-occurring disorders in people with substance use disorders and review basic therapeutic and pharmacologic interventions. This training satisfies 1.00 hours of the required 8 hours of training for DEA-registered practitioners. Intended audience: Medical professionals with prescriptive authority, nurses and support staff who support them looking to increase provision of care for patients with substance use disorder. For more information… Read more »
Integrating Addiction Treatment into Your Practice: A How-To Guide
Sponsor: Grayken Center for Addiction TTA, a program of Boston Medical Center Description: This training will provide strategies to implementing addiction care and medications for OUD into your practice setting. This training satisfies 1.00 hours of the required 8 hours of training for DEA-registered practitioners. Intended audience Intended audience: Medical professionals with prescriptive authority, nurses and support staff who support them looking to increase provision of care for patients with substance use disorder. Objectives Following this training,… Read more »
Management of Other Substance Use Disorders: Alcohol and Benzodiazepines
Sponsor: Grayken Center for Addiction TTA, a program of Boston Medical Center Description This training will review strategies for managing alcohol use disorders and benzodiazepine use disorders. This training satisfies 1.00 hours of the required 8 hours of training for DEA-registered practitioners. Intended audience Medical professionals with prescriptive authority, nurses and support staff who support them looking to increase provision of care for patients with substance use disorder. Objectives Following this training, participants will have the knowledge… Read more »
Medical Considerations for People with Substance Use Disorder
Sponsor: Grayken Center for Addiction TTA, a program of Boston Medical Center Description This training will review medical conditions commonly seen in people using substances. This training satisfies 1.00 hours of the required 8 hours of training for DEA-registered practitioners. Objectives Following this training, participants will have the knowledge necessary to: For more information and to register click here
Management of Other Substance Use Disorders: Stimulants
Sponsor: Boston Medical Center Grayken Center for Addiction Training and Technical Assistance, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS) Description This training will introduce participants to stimulant use disorders. Objectives Following this training, participants will have the knowledge necessary to: For more information and to register click here
Advancing Addiction Treatment: Building Knowledge of Substance Use and Specialty Topics
Sponsor: Grayken Center for Addiction, a program of Boston Medical Center Description This training describes the principles of harm reduction and offers strategies to support persons who use drugs and their community members. This training satisfies 0.75 hours of the required 8 hours of training for DEA-registered practitioners. The Medication Access and Training Expansion (MATE) Act was included in the Consolidated Appropriations Act, 2023. The MATE Act requires increased training for Drug Enforcement Administration (DEA)-registered physicians and practitioners—specifically, a one-time… Read more »
The Muscarinic Cholinergic System’s Role in Schizophrenia: Pathophysiology and Emerging Treatments
Sponsor: HMP Education: Global Learning Network This on-demand activity discusses strategies for patient-centered communication, including shared decision-making and motivational interviewing, to facilitate treatment selection and acceptance. Learning Objectives: After participating in this activity, learners should be better able to: For more information and to register click here
Synthetic Opioids: Navigating the Changing Landscape of Opioid Use Disorder
Sponsor: UR Medicine Recovery Centr of Excellence This 35-minute self-paced module focuses on how primary care providers can navigate the changing landscape of opioid use disorder in relation to synthetic opioids. The module discusses synthetic overdose in relation to fentanyl and fentanyl analogs, as well as the dangers of xylazine. It provides treatment recommendations for patients who use synthetic opioids and overdose prevention strategies. For more information and to access click here
8-hour training for new or renewing DEA licenses
A new law soon goes into effect that requires new or renewing DEA licensees, as of June 27, 2023, to have completed a total of at least eight hours of training on opioid or other substance use disorders and the appropriate treatment of pain. Dr Yngvild Olsen, director of the Center for Substance Abuse Treatment at the Substance Abuse and Mental Health Services Administration, joins us to discuss the requirements going into effect, what should… Read more »